Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 18,500 shares, a decrease of 43.6% from the March 31st total of 32,800 shares. Based on an average daily volume of 391,900 shares, […]
Revelation Biosciences (NASDAQ:REVB – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($8.33) earnings per share (EPS) for the quarter, topping the consensus estimate of ($10.94) by $2.61, reports. Revelation Biosciences Stock Performance NASDAQ REVB traded down $0.01 during trading hours on Monday, hitting $2.36. 23,211 shares of the company […]
Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report)’s share price dropped 1.3% on Thursday . The stock traded as low as $0.41 and last traded at $0.43. Approximately 16,415 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 63,276 shares. The stock had previously closed at $0.44. Revelation […]
Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report)’s share price fell 1.3% on Thursday . The company traded as low as $0.41 and last traded at $0.43. 16,415 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 63,276 shares. The stock had previously closed at $0.44. Revelation Biosciences […]
Shares of Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) were down 5.5% during mid-day trading on Monday . The stock traded as low as $0.59 and last traded at $0.60. Approximately 20,590 shares traded hands during trading, a decline of 94% from the average daily volume of 322,707 shares. The stock had previously closed […]